We already use our smartphones for just about everything. From ordering a late-night pizza to tracking our sleep patterns and desperately trying to remember where we parked the car. But what if that very same device sitting in your pocket right now could do something profoundly more important? What if it could objectively diagnose mental health conditions like Post-Traumatic Stress Disorder (PTSD) without you having to say a single word?
It sounds like something straight out of a science fiction movie, but it is entirely real. A massive, fully virtual clinical trial is currently rolling out across Australia, aiming to turn an ordinary iPhone into a groundbreaking diagnostic device.
The Story Behind the Tech
Mental health remains one of Australia’s most pressing hurdles. Statistics tell us that over one in five Australians experience a mental disorder in any given year, with anxiety disorders leading the charge. When it comes to PTSD, around 11% of Australians will face it in their lifetime. Yet, getting a formal diagnosis is far from simple.
Currently, to get a PTSD diagnosis, you are looking at a structured clinical interview that can easily take 90 minutes or more. It relies heavily on a physician’s expertise and, crucially, a patient’s ability to accurately remember and describe deeply personal, often traumatic symptoms. This can be an exhausting barrier for anyone, particularly veterans, first responders, and people living in regional or remote communities who cannot easily access specialist clinics.
Enter the Senseye Diagnostic Tool (Senseye DT). Evrima Technologies has launched one of the largest global studies of its kind right here in Australia to train and test this software. The ultimate goal? To make Senseye DT the world’s first authorised diagnostic device for PTSD.
How It Works: The Mechanics of the Mind
So, how does an app actually peer into your mental state? It is all about the eyes.
The Senseye DT operates exclusively on an iPhone 13 or newer. It uses the phone’s front-facing camera to record video of your face while you complete a series of simple visual tasks. Using patented computer vision technology and a machine-learning algorithm, it analyses subtle eye movement patterns, pupil responses, and gaze behaviours. Essentially, there are physiological digital biomarkers expressed by your eyes that can indicate PTSD, completely bypassing the need for a subjective interview.
Participants in the study download the app and are guided over five weeks by qualified psychologists. It involves about nine hours of activity in total, all done from the absolute comfort of your own couch. No medical treatments are involved—it is purely about training the algorithm to recognise the physiological signals of PTSD, as well as distinguishing it from general anxiety and depression.
Seeking support for mental health takes an enormous amount of courage. If a technology can make that first diagnostic step faster, more accessible, and completely objective, it is a monumental win. By participating in this study, Australians have a unique chance to help shape a tool that could revolutionise mental health care globally. If you have an iPhone 13 or newer and are experiencing symptoms related to anxiety, depression, or PTSD, you can actually register to be part of the change.
Recruitment is open now with individuals encouraged to visit www.evrima.com/active-trials to learn more about the study, or speak to their GP or healthcare professional.
